FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1964480573> ?p ?o ?g. }

• W1964480573 abstract "Inducible cyclooxgenase-2 (COX-2) is commonly overexpressed in breast tumors and is a target for cancer therapy. Here, we studied the association of COX-2 with breast cancer survival and how this association is influenced by tumor estrogen and HER2 receptor status and Akt pathway activation.Tumor COX-2, HER2 and estrogen receptor α (ER) expression and phosphorylation of Akt, BAD, and caspase-9 were analyzed immunohistochemically in 248 cases of breast cancer. Spearman's correlation and multivariable logistic regression analyses were used to examine the relationship between COX-2 and tumor characteristics. Kaplan-Meier survival and multivariable Cox proportional hazards regression analyses were used to examine the relationship between COX-2 and disease-specific survival.COX-2 was significantly associated with breast cancer outcome in ER-negative [Hazard ratio (HR) = 2.72; 95% confidence interval (CI), 1.36-5.41; comparing high versus low COX-2] and HER2 overexpressing breast cancer (HR = 2.84; 95% CI, 1.07-7.52). However, the hazard of poor survival associated with increased COX-2 was highest among patients who were both ER-negative and HER2-positive (HR = 5.95; 95% CI, 1.01-34.9). Notably, COX-2 expression in the ER-negative and HER2-positive tumors correlated significantly with increased phosphorylation of Akt and of the two Akt targets, BAD at Ser136 and caspase-9 at Ser196.Up-regulation of COX-2 in ER-negative and HER2-positive breast tumors is associated with Akt pathway activation and is a marker of poor outcome. The findings suggest that COX-2-specific inhibitors and inhibitors of the Akt pathway may act synergistically as anticancer drugs in the ER-negative and HER2-positive breast cancer subtype." @default.
• W1964480573 created "2016-06-24" @default.
• W1964480573 creator A5002365439 @default.
• W1964480573 creator A5017672961 @default.
• W1964480573 creator A5031481108 @default.
• W1964480573 creator A5032145876 @default.
• W1964480573 creator A5032870776 @default.
• W1964480573 creator A5044929543 @default.
• W1964480573 creator A5047942023 @default.
• W1964480573 creator A5052087705 @default.
• W1964480573 creator A5053260313 @default.
• W1964480573 creator A5072175033 @default.
• W1964480573 date "2010-11-15" @default.
• W1964480573 modified "2023-10-07" @default.
• W1964480573 title "COX-2 activation is associated with Akt phosphorylation and poor survival in ER-negative, HER2-positive breast cancer" @default.
• W1964480573 cites W1863087187 @default.
• W1964480573 cites W1968442275 @default.
• W1964480573 cites W1969780570 @default.
• W1964480573 cites W1976565595 @default.
• W1964480573 cites W1981672008 @default.
• W1964480573 cites W1984754931 @default.
• W1964480573 cites W1988747916 @default.
• W1964480573 cites W2001529630 @default.
• W1964480573 cites W2023648132 @default.
• W1964480573 cites W2041140906 @default.
• W1964480573 cites W2046917725 @default.
• W1964480573 cites W2049475256 @default.
• W1964480573 cites W2050683019 @default.
• W1964480573 cites W2051135482 @default.
• W1964480573 cites W2063284947 @default.
• W1964480573 cites W2064242629 @default.
• W1964480573 cites W2077371239 @default.
• W1964480573 cites W2082770517 @default.
• W1964480573 cites W2083573754 @default.
• W1964480573 cites W2087739228 @default.
• W1964480573 cites W2097669235 @default.
• W1964480573 cites W2100155438 @default.
• W1964480573 cites W2112893608 @default.
• W1964480573 cites W2114808102 @default.
• W1964480573 cites W2117115931 @default.
• W1964480573 cites W2129377268 @default.
• W1964480573 cites W2131994307 @default.
• W1964480573 cites W2157158866 @default.
• W1964480573 cites W2162047243 @default.
• W1964480573 cites W2169532459 @default.
• W1964480573 cites W2182021524 @default.
• W1964480573 cites W2319962899 @default.
• W1964480573 doi "https://doi.org/10.1186/1471-2407-10-626" @default.
• W1964480573 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2993681" @default.
• W1964480573 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21078168" @default.
• W1964480573 hasPublicationYear "2010" @default.
• W1964480573 type Work @default.
• W1964480573 sameAs 1964480573 @default.
• W1964480573 citedByCount "57" @default.
• W1964480573 countsByYear W19644805732012 @default.
• W1964480573 countsByYear W19644805732013 @default.
• W1964480573 countsByYear W19644805732014 @default.
• W1964480573 countsByYear W19644805732015 @default.
• W1964480573 countsByYear W19644805732016 @default.
• W1964480573 countsByYear W19644805732017 @default.
• W1964480573 countsByYear W19644805732018 @default.
• W1964480573 countsByYear W19644805732019 @default.
• W1964480573 countsByYear W19644805732020 @default.
• W1964480573 countsByYear W19644805732021 @default.
• W1964480573 countsByYear W19644805732022 @default.
• W1964480573 countsByYear W19644805732023 @default.
• W1964480573 crossrefType "journal-article" @default.
• W1964480573 hasAuthorship W1964480573A5002365439 @default.
• W1964480573 hasAuthorship W1964480573A5017672961 @default.
• W1964480573 hasAuthorship W1964480573A5031481108 @default.
• W1964480573 hasAuthorship W1964480573A5032145876 @default.
• W1964480573 hasAuthorship W1964480573A5032870776 @default.
• W1964480573 hasAuthorship W1964480573A5044929543 @default.
• W1964480573 hasAuthorship W1964480573A5047942023 @default.
• W1964480573 hasAuthorship W1964480573A5052087705 @default.
• W1964480573 hasAuthorship W1964480573A5053260313 @default.
• W1964480573 hasAuthorship W1964480573A5072175033 @default.
• W1964480573 hasBestOaLocation W19644805731 @default.
• W1964480573 hasConcept C11960822 @default.
• W1964480573 hasConcept C121608353 @default.
• W1964480573 hasConcept C126322002 @default.
• W1964480573 hasConcept C143998085 @default.
• W1964480573 hasConcept C207103383 @default.
• W1964480573 hasConcept C44249647 @default.
• W1964480573 hasConcept C50382708 @default.
• W1964480573 hasConcept C530470458 @default.
• W1964480573 hasConcept C55493867 @default.
• W1964480573 hasConcept C71924100 @default.
• W1964480573 hasConcept C75217442 @default.
• W1964480573 hasConcept C84606932 @default.
• W1964480573 hasConcept C86803240 @default.
• W1964480573 hasConceptScore W1964480573C11960822 @default.
• W1964480573 hasConceptScore W1964480573C121608353 @default.
• W1964480573 hasConceptScore W1964480573C126322002 @default.
• W1964480573 hasConceptScore W1964480573C143998085 @default.
• W1964480573 hasConceptScore W1964480573C207103383 @default.
• W1964480573 hasConceptScore W1964480573C44249647 @default.
• W1964480573 hasConceptScore W1964480573C50382708 @default.
• W1964480573 hasConceptScore W1964480573C530470458 @default.
• W1964480573 hasConceptScore W1964480573C55493867 @default.

• next